BUSM Study Reveals B cells as Therapeutic Targets to Alter Obesity-Associated Inflammation and Type 2 Diabetes
New research from Boston University School of Medicine (BUSM) reveals that B cells regulate obesity-associated inflammation and type 2 diabetes through two specific mechanisms. The study, published in the Proceedings of the National Academies of Sciences, indicates the importance of continuing to explore B cells as a therapeutic target to treat these diseases. Barbara Nikolajczyk, More
BUSM Study Reveals Potential Target to Better Treat, Cure Anxiety Disorders
Researchers at Boston University School of Medicine (BUSM) have, for the first time, identified a specific group of cells in the brainstem whose activation during rapid eye movement (REM) sleep is critical for the regulation of emotional memory processing. The findings, published in the Journal of Neuroscience, could help lead to the development of effective... More
“Safe, long-term opioid therapy is possible” according to BUSM’s Alford in JAMA
In a Clinical Crossroads article featured in the March 6, 2013 issue of the Journal of the American Medical Association (JAMA), Dr. Dan Alford from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) suggests that prescription opioid abuse can be minimized by monitoring patients closely for harm by using urine drug testing... More
ART DAYS 2013, Share Your Creativity
ART DAYS 2013 MONDAY-TUESDAY, April 1-2, 9 a.m.-5 p.m. RECEPTIONS BOTH DAYS at 3 p.m. BUSM Instructional Building, Hiebert Lounge All students, faculty and staff from all schools on the BU Medical Campus are encouraged to submit artwork of any medium to the 23rd annual Boston University School of Medicine gallery for the arts. "Art Days" ... More
BUSM Researchers Use Goal-Oriented Therapy to Treat Diabetic Neuropathies
Researchers at Boston University School of Medicine (BUSM) and VA Boston Healthcare System (VA BHS) have found that cognitive behavioral therapy (CBT) can help relieve pain for people with painful diabetic neuropathies. The study, which is the first of its kind to examine this treatment for people with type II diabetes mellitus, is published in... More
International consortium discovers seven new genomic regions associated with AMD
An international group of researchers has discovered seven new regions of the human genome—called loci—that are associated with increased risk of age-related macular degeneration (AMD), a leading cause of blindness. The AMD Gene Consortium, a network of international investigators representing 18 research groups, also confirmed 12 loci identified in previous studies. The study, which is... More
Mechanisms Regulating Inflammation Associated with Type 2 Diabetes, Cancer Identified
(Boston) – A study led by researchers at Boston University School of Medicine (BUSM) has identified epigenetic mechanisms that connect a variety of diseases associated with inflammation. Utilizing molecular analyses of gene expression in macrophages, which are cells largely responsible for inflammation, researchers have shown that inhibiting a defined group of proteins could help decrease... More
Getting Ready for Sequestration: BU Already Tightening the Belt
How will sequestration affect research at Boston University? The School of Medicine already is taking a 10 percent haircut on some federal grants that were promised, but are being withheld, forcing some lab staff layoffs. David Coleman, a MED professor and chair of the department of medicine, fears a slowdown in its studies of how... More
Wainford Recognized by American Physiological Society
Richard Wainford, PhD, is the recipient of the American Physiological Society 2013 Shih-Chun Wang Young Investigator Award. This award was established in 1998, in memory of Shih-Chun Wang, to recognize an individual demonstrating outstanding promise in the field of central nervous system physiology. In addition, the award includes $4000 for use in support of... More
BUSM Researchers Propose Potential Epigenetic Mechanisms for Improved Cancer Therapy
(Boston) – A review article by BUSM researchers proposes a new epigenetic hypothesis linked to tumor production and novel ideas about what causes progenitor cells to develop into cancer cells. Published in the February 2013 issue of Epigenomics, the article provides examples of how epigenetic drug treatments could be beneficial in treating cancers while also... More
